₹ 273600 / 2400 Shares Shares
Minimum Investment
₹108-114 per equity share
11 Nov 2025
13 Nov 2025
1200
₹ 273600
₹108-114
18 Nov 2025
61,78,800 shares(aggregating up to ₹70.44 crore)
₹10 Per Equity Share
2400 Shares
2400 Shares
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity. The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs. The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
2002
Mr. Krishnamurthy Ganesan
Mahamaya Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹108-114 | ₹2,73,600 |
| Individual(max) | ₹108-114 | ₹2,73,600 |
| SHNI(min) | ₹108-114 | ₹4,10,400 |
| SHNI(max) | ₹108-114 | ₹9,57,600 |
| BHNI(min) | ₹108-114 | ₹10,94,400 |
Apply for all eligible candidates, Mahamaya Lifesciences Limited IPO
While SIPs are subject to market risks, long-term investing and diversification help reduce risk and improve returns.
Yes, KSquare allows you to modify or increase your SIP contributions easily as your income or goals change.
Typically, equity and debt mutual fund units held in demat form are eligible. KSquare helps confirm your fund’s eligibility instantly.
The loan value is based on the mutual fund's NAV and the lender’s margin requirements. KSquare shows your eligible amount during application.
Yes, KSquare’s digital platform enables secure and quick online investments in NFOs with just a few clicks.
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
Yes, returns are subject to TDS based on fund type and holding period. KSquare helps you plan for this.
SIP is equally beneficial for business owners, helping them invest steadily despite fluctuating income.